Turing Pharmaceuticals
Recent Finacing
Hybrid A
Recent Raise
$90M
Turing Pharmaceuticals AG (NYC, Zug) discovers, develops and commercializes drugs for serious diseases, including intranasal ketamine, Syntocinon oxytocin nasal solution, Vecamyl for hypertension, and U.S. Daraprim rights.
Highlights
Focus Areas
Biopharma
Biotechnology
Medical
Financials
$90M
Total Raised
1
Funding round